Glenmark pharma share price graph
Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6072.35 Crore to Sales Value (96.31 % of Total Sales), Other Operating Revenue which contributed Rs 173.73 Crore to Sales Value (2.75 % of Total Sales) and Sale of services which contributed Rs 58.79 Crore to Sales Value (0.93 % of Total Sales)for the year ending 31-Mar-2019. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following segments: India, United States, Latin America, Europe, and Rest of the World. The stock of Glenmark Pharmaceuticals can be bought with a target price of Rs 500 as the company continues to remain confident on achieving single-digit growth in FY20E despite a persisting decline in gMupirocin sales. Glenmark Pharmaceuticals up by 0.78% is trading at ₹ 219.50 today. Get live share price chart, key metrics, forecast and ratings of Glenmark Pharmaceuticals Ltd - GLENMARK on Tickertape Access our live advanced streaming chart forGlenmark Pharmaceuticals Ltd Share, free of charge. This unique "area" or candle chart enables you to clearly notice the movements of this Glenmark Pharma share within the last hours of trading, as well as providing you with key data such as the daily change, high and low prices.
Glenmark Pharmaceuticals Stock Forecast, "GLENMARK" Share Price Prediction Charts Is "Glenmark Pharmaceuticals Ltd" a Good Investment? Current price today: 209.450 INR (+1.972%)
Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6072.35 Crore to Sales Value (96.31 % of Total Sales), Other Operating Revenue which contributed Rs 173.73 Crore to Sales Value (2.75 % of Total Sales) and Sale of services which contributed Rs 58.79 Crore to Sales Value (0.93 % of Total Sales)for the year ending 31-Mar-2019. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following segments: India, United States, Latin America, Europe, and Rest of the World. The stock of Glenmark Pharmaceuticals can be bought with a target price of Rs 500 as the company continues to remain confident on achieving single-digit growth in FY20E despite a persisting decline in gMupirocin sales. Glenmark Pharmaceuticals up by 0.78% is trading at ₹ 219.50 today. Get live share price chart, key metrics, forecast and ratings of Glenmark Pharmaceuticals Ltd - GLENMARK on Tickertape Access our live advanced streaming chart forGlenmark Pharmaceuticals Ltd Share, free of charge. This unique "area" or candle chart enables you to clearly notice the movements of this Glenmark Pharma share within the last hours of trading, as well as providing you with key data such as the daily change, high and low prices.
Industry:Pharma; Market cap:Rs 6,788.00 Cr (Mid Cap); P/E: 10.20Industry P/E: term financial; Valuation - Attractiveness today; CFT - Current financial trend
Get today's Glenmark Pharmaceuticals Ltd. share price details along with futures & options quotes. Get detailed report in terms of MF holding details, financials,
Share market update: BSE Midcap index down; Glenmark Pharma plunges 21% - 5 day(s) ago GLENMARK PHARMA Surges by 12%; BSE HEALTHCARE Index Down 0.3% - 1 day(s) ago Glenmark Q3 net profit rises 64% to Rs 190.83 cr; to raise $400 mn - 14 Feb 2020
Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following segments: India, United States, Latin America, Europe, and Rest of the World. Moneycontrol Technical Chart Analysis of Glenmark, BSE/NSE Market chart analysis,live market index & techical information with graph in advance features. Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6072.35 Crore to Sales Value (96.31 % of Total Sales), Other Operating Revenue which contributed Rs 173.73 Crore to Sales Value (2.75 % of Total Sales) and Sale of services which contributed Rs 58.79 Crore to Sales Value (0.93 % of Total Sales)for the year ending 31-Mar-2019. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following segments: India, United States, Latin America, Europe, and Rest of the World. The stock of Glenmark Pharmaceuticals can be bought with a target price of Rs 500 as the company continues to remain confident on achieving single-digit growth in FY20E despite a persisting decline in gMupirocin sales. Glenmark Pharmaceuticals up by 0.78% is trading at ₹ 219.50 today. Get live share price chart, key metrics, forecast and ratings of Glenmark Pharmaceuticals Ltd - GLENMARK on Tickertape
Glenmark Pharmaceuticals Live NSE/BSE Share Price: Get Glenmark Pharmaceuticals Stock Price details, News, Financial Results, Stock Charts, Returns,
Glenmark Pharmaceuticals Limited (GLENMARK.NS). NSE - NSE Real Time Price. Currency in INR. This page features historic data for the Glenmark Pharmaceuticals Ltd share ( GLEN) as well as the closing price, open, high, low, change and %change. Get today's Glenmark Pharmaceuticals Ltd. share price details along with futures & options quotes. Get detailed report in terms of MF holding details, financials, Glenmark Pharmaceuticals Live NSE/BSE Share Price: Get Glenmark Pharmaceuticals Stock Price details, News, Financial Results, Stock Charts, Returns, Share Price, Corporate Actions, Valuation, Research Report, Financials and more - complete track record of Glenmark Pharmaceuticals Ltd.. From Indias independent mutual fund research Price Graph. Piramal Enterprises. Lupin. S&P BSE GLENMARK Share Price Today Key Fundamentals of GLENMARK PHARMACEUTICALS. Sector We donot recomend daily/intraday minuite, hourly charts.
Get today's Glenmark Pharmaceuticals Ltd. share price details along with futures & options quotes. Get detailed report in terms of MF holding details, financials, Glenmark Pharmaceuticals Live NSE/BSE Share Price: Get Glenmark Pharmaceuticals Stock Price details, News, Financial Results, Stock Charts, Returns, Share Price, Corporate Actions, Valuation, Research Report, Financials and more - complete track record of Glenmark Pharmaceuticals Ltd.. From Indias independent mutual fund research Price Graph. Piramal Enterprises. Lupin. S&P BSE GLENMARK Share Price Today Key Fundamentals of GLENMARK PHARMACEUTICALS. Sector We donot recomend daily/intraday minuite, hourly charts. 19 Feb 2020 The Glenmark Pharmaceuticals (NSE:GLENMARK) Share Price Is Down most people consider earnings and revenue growth trends to be a Industry:Pharma; Market cap:Rs 6,788.00 Cr (Mid Cap); P/E: 10.20Industry P/E: term financial; Valuation - Attractiveness today; CFT - Current financial trend